| Document |
Document Title |
|
WO/2022/262384A1 |
The present invention relates to the field of genetic engineering, and disclosed is a method for increasing the yield of spinosyns of Saccharopolyspora spinosa. The method of the present invention is to overexpress a spnF gene and/or a s...
|
|
WO/2022/262591A1 |
A method for purifying ansamitocin P-3, comprising using a resin to adsorb an ansamitocin fermentation solution, using an organic solvent for resolution, collecting and concentrating a resolution solution, subjecting the resolution solut...
|
|
WO/2022/261820A1 |
Provided is a SS15 strain of a Bacillus sp. for producing a bioflocculant and a biosurfactant, with the deposit number thereof being CCTCC M 2021295. The 16S rRNA sequence of the strain is as shown in SEQ ID NO: 1. The strain can be used...
|
|
WO/2022/239916A9 |
The present invention relates to a novel Bifidobacterium longum strain and use thereof and, more particularly, to a novel Bifidobacterium longum subsp. Infantis YB0411 strain having anti-obesity activity, and a pharmaceutical composition...
|
|
WO/2022/257757A1 |
Disclosed is a mutant of a corynebacterium glutamicum dihydrodipicolinate reductase (dapB) gene promoter. Compared with the promoter of a wild-type dapB gene, the promoter activity of the mutant is significantly improved. Also disclosed ...
|
|
WO/2022/260402A1 |
The present invention relates to: an atranorin biosynthesis gene derived from the lichen Stereocaulon alpinum; an Ascochyta rabiei) ATR-11 strain (accession number: KACC83048BP), having the gene introduced thereinto, for producing atrano...
|
|
WO/2022/257305A1 |
The present invention provides a foundation pit microbial soil gravity enclosure structure and a construction method therefor. The microbial soil gravity enclosure structure relates to mixing a composite bacterial solution, a cementing s...
|
|
WO/2022/256882A1 |
The present invention relates to extracted microbial lipids, microbial cells comprising the lipid, and extracts thereof. The present invention also relates to use of these lipids, cells and extracts in foods, feedstuffs and beverages.
|
|
WO/2022/257758A1 |
A polynucleotide having promoter activity of a malate dehydrogenase gene (mdh gene), a transcription expression cassette, recombinant expression vector and recombinant host cell containing the polynucleotide having the promoter activity,...
|
|
WO/2022/257391A1 |
Provided are a new Rheinheimera strain (Rheinheimera indica) SM2107 and the use thereof. The deposit number of the strain is CCTCC M 2021506. The strain has the capacity to degrade collagen and can be used for preparing collagenase. The ...
|
|
WO/2022/252619A1 |
A fermentation and enzymolysis preparation method for small peptides from a leaf-shaped fish and the use thereof. The preparation process comprises: crushing, degreasing and hydrolyzing a leaf-shaped fish to obtain a hydrolysate; carryin...
|
|
WO/2022/254384A1 |
The disclosure provides a strain of Beauveria spp. fungi. The disclosed Beauveria strain may be in a symbiotic association with a host plant, particularly a Brassicaceae host plant. Also disclosed are methods of using the disclosed Beauv...
|
|
WO/2022/252185A1 |
An oncolytic virus vector and the use thereof in the preparation of a drug for treating a cancer. The oncolytic virus vector contains a recombinant nucleic acid comprising: (i) a first nucleic acid fragment encoding a soluble PD-1 molecu...
|
|
WO/2022/253002A1 |
Provided in the present application are a Phlebopus portentosus strain and the use thereof in the production of Phlebopus portentosus. The strain is obtained from the self-hybridization of YL1701-2, and was deposited in the China General...
|
|
WO/2022/251933A1 |
The present disclosure provides recombinant microorganisms and methods for producing malonate semialdehyde and/or related products, such as ketones, alcohols, organic acids, esters, alkenes, amino acids, and combinations thereof includin...
|
|
WO/2022/252745A1 |
A kit for the detection of virus particles using immune molecules. A monoclonal antibody of a virus envelope antigen is subjected to biotin modification, and a magnetic bead is coupled with streptavidin; then, the biotin-modified monoclo...
|
|
WO/2022/253175A1 |
A synthetic polymeric porous medium with a core-shell (s) hierarchical layer structure and has an essentially homogeneous porous structure from inside to outside of the medium, whose core and shell (s) are covalently modified with distin...
|
|
WO/2022/249034A1 |
This invention provides a recombinant Escherichia coli (E.coli) host cell for producing a Klebsiella pneumoniae (K.pneumoniae) O-antigen, wherein the E.coli host cell comprises a polynucleotide encoding the K.pneumoniae O-antigen, includ...
|
|
WO/2022/246646A1 |
Provided are a chimeric oncolytic adenovirus simultaneously expressing IL-12, IFN-γ, and CCL5, and an application thereof in tumor treatment. A capsid protein hexon of the oncolytic adenovirus is formed from chimerizing hexon sequences ...
|
|
WO/2022/246810A1 |
A preparation method for a polyketone compound having anti-novel coronavirus activity, and an application of a polyketone compound. Solid fermentation is performed on alternaria endophytic fungi Alternaria sp., and a polyketone monomeric...
|
|
WO/2022/251056A1 |
The present invention relates to transcriptional regulator polypeptides, polynucleotides encoding the transcriptional regulator polypeptides, and to nucleic acid constructs, vectors and host cells comprising the polynucleotides as well a...
|
|
WO/2022/247225A1 |
Provided are a symbiotic bacteria composition, a preparation method therefor, and a culture method for microalgae. The symbiotic bacteria composition is composed of marine Clostridium butyricum, marine red yeast, and marine purple non-su...
|
|
WO/2022/250192A1 |
The present invention relates to novel strain Lactobacillus fermentum E4 derived from kimchi, which is a Korean traditional fermented food, and a method for mass-producing the strain. The Lactobacillus fermentum E4 of the present inventi...
|
|
WO/2022/246954A1 |
A Lampropedia strain, a Lampropedia strain cell suspension, and an application thereof in prevention and control of capsicum fusarium wilt. The Lampropedia strain (Lampropedia sp.) has a number of M1031, and is preserved in the General M...
|
|
WO/2022/250389A1 |
The present invention relates to a Dunariella salina OH214 strain having an improved ability to produce pigments, and in particular, lutein. As it is possible to produce carotenoid pigments, specifically xanthophylls, with the Dunariella...
|
|
WO/2022/250557A1 |
The object of the invention is a process for the isolation and culture of strains, the strains, use thereof, media for culturing thereof and a form of scytonemin.
|
|
WO/2022/246811A1 |
The present invention relates to the field of compound synthesis, and provides a polyketone compound and a preparation method therefor. In the present invention, solid fermentation is performed on Alternaria sp., and a series of separati...
|
|
WO/2022/250516A1 |
The present invention relates to a microorganism with a reduced mucilage production ability, a method for preparing fermented soy product by using same, and a fermented soy product prepared thereby and a use thereof.
|
|
WO/2022/247618A2 |
|
|
WO/2022/247190A1 |
Provided is a high camptothecin yielding endophytic strain, which is selected from Alternaria tenuissima ZCMUKL-S1 having the preservation number CCTCC NO: M2021189, or Alternaria citricancri ZCMUKL-S2 having the preservation number CCTC...
|
|
WO/2022/242637A1 |
Provided is a method for inexpensively producing L-isoleucine at a higher yield by means of a fermentation method, comprising: using a genetic engineering method to obtain a genetically engineered strain, the genetically engineered strai...
|
|
WO/2022/243052A1 |
The present invention is in the field of dairy technology. It relates to a method for producing a fermented milk product comprising the steps: (a) Providing a starter culture comprising one or more lactic acid bacteria strains selected f...
|
|
WO/2022/242033A1 |
Provided in the present invention are a genetically engineered bacterium for producing porcine myoglobin, and methods for fermenting and purifying same. According to the present invention, the gene of the porcine myoglobin is integrated ...
|
|
WO/2022/243314A2 |
The present disclosure relates to a method for the production of a human milk oligosaccharide (HMO) blend with LNFP-I and 2'-FL as the predominant HMO's, the method comprising the steps of providing a genetically engineered cell, which c...
|
|
WO/2022/242446A1 |
Disclosed in the present invention is a strain of Lactobacillus plantarum guanke, wherein the strain has the deposit number CGMCC NO. 21720, was deposited on 22 January, 2021, has the classification name Lactobacillus plantarum guanke, a...
|
|
WO/2022/243311A1 |
The present disclosure relates to a genetically modified cell capable of utilizing sucrose as energy and carbon source following the expression of a single heterologous enzyme, which upon expression is translocated from the cytosol and w...
|
|
WO/2022/243315A1 |
The present disclosure relates to a method for the production of a human milk oligosaccharide (HMO) blend with LNFP-I and 2'-FL as the predominant HMO's, the method comprising the steps of providing a genetically engineered cell, which c...
|
|
WO/2022/243312A1 |
The present disclosure discloses the identification and introduction of a specific heterologous gene (denoted as smob), which encodes an a-l,2-fucosyltransferase, into an LNT production strain to produce LNFP-I in particular. The smob ge...
|
|
WO/2022/243558A1 |
The present invention relates to a bacterial cell wall or fragment thereof of a selected Gram-positive strain of Cutibacterium acnes linked with a mucopolysaccharide andto its uses in the prevention or treatment of an immunological disea...
|
|
WO/2022/242570A1 |
Provided are a nitrogen-fixing compound bacterial system comprising nitrogen-fixing bacteria and non-nitrogen-fixing bacteria, and an application thereof, the nitrogen-fixing bacteria comprising Klebsiella MNAZ1050, Citrobacter MNAZ1397 ...
|
|
WO/2022/243310A1 |
The present disclosure relates to a genetically modified cell capable of utilizing sucrose as energy and carbon source following the expression of a single heterologous enzyme, which upon expression is translocated from the cytosol and w...
|
|
WO/2022/236935A1 |
Disclosed are a probiotic having an effect of inhibiting the growth of Proteus mirabilis, and a fermentation broth and the use thereof, and same belong to the technical field of microorganisms. The probiotic having the effect of inhibiti...
|
|
WO/2022/240910A1 |
Set forth herein is a composition that includes a fungal pellet and animal cells, wherein the animal cells are in connection with the fungal pellet. The animal cells can be located on the exterior surface of the fungal pellet, the interi...
|
|
WO/2022/236365A1 |
This disclosure relates generally to the field of therapeutic compositions comprising bacterialstrains and methods for the treatment or prevention of disease. More particularly, the disclosurerelates to compositions comprising bacterial ...
|
|
WO/2022/238329A1 |
Provided herein are compositions, e.g., starter cultures, containing Lactococcus laudensis and methods of using the same to produce fermented milk products.
|
|
WO/2022/238645A1 |
The present invention relates to the field of the production of phenylpropanoid compounds, especially that of genetically modified strains for the production of phenylpropanoid compounds. In particular, the invention relates to a genetic...
|
|
WO/2022/237224A1 |
The present invention provides a recombinant human type XVII collagen, the collagen consisting of an amino acid sequence shown represented by (A)n or comprising the amino acid sequence represented by (A)n, wherein A is a sequence shown i...
|
|
WO/2022/236527A1 |
Disclosed in the present application is a method for preventing harmful bacterial biofilm formation on the surface of a stainless steel product, comprising: providing a Lactobacillus plantarum bacterial solution, the bacterial solution c...
|
|
WO/2022/233623A1 |
Suggested are new microbial glycolipids of formula (I), wherein X stands for nitrogen or oxygen; R1 represents hydrogen, -CO-Alkyl, -CO-Aryl, -CO-N-Alkyl, -CO-N-Aryl, SO2-Alkyl, SO2-Aryl, -CO(CH2)nCOOH with n=1 to 4, or an amino acid; R2...
|
|
WO/2022/234836A1 |
Provided is technology for controlling fermentation. A foam surface during fermentation is detected using a non-contact means such as a laser, the degree of foaming is calculated, and the addition of a defoaming agent is controlled accor...
|
